Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant Ifosfamide and radiation therapy.

Literature DB >> 22869889

Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant Ifosfamide and radiation therapy.

Kyle C Cuneo¹, Richard F Riedel, Leslie G Dodd, David H Harpole, David G Kirsch.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2012 PMID： 22869889 PMCID： PMC4874177 DOI： 10.1200/JCO.2012.42.8797

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

× No keyword cloud information.

23 in total

1. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma.

Authors: Ching-Wei D Tzeng; John B Fiveash; Richard A Popple; J Pablo Arnoletti; Suzanne M Russo; Marshall M Urist; Kirby I Bland; Martin J Heslin
Journal: Cancer Date: 2006-07-15 Impact factor: 6.860

Review 2. Evidence-based recommendations for local therapy for soft tissue sarcomas.

Authors: Peter W T Pisters; Brian O'Sullivan; Robert G Maki
Journal: J Clin Oncol Date: 2007-03-10 Impact factor: 44.544

Review 3. Utility of positron emission tomography in sarcomas.

Authors: Scott M Schuetze
Journal: Curr Opin Oncol Date: 2006-07 Impact factor: 3.645

4. Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy.

Authors: Christian H Brandts; Christiane Schulz; Normann Willich; Björn Steffen; Jendrik Hardes; Georg Gosheger; Winfried Winkelmann; Hubert Serve; Achim Heinecke; Wolfgang E Berdel; Michael Thomas
Journal: Cancer Chemother Pharmacol Date: 2011-09-24 Impact factor: 3.333

5. Primary pulmonary sarcoma: a clinicopathologic study of 26 cases.

Authors: S B Keel; E Bacha; E J Mark; G P Nielsen; A E Rosenberg
Journal: Mod Pathol Date: 1999-12 Impact factor: 7.842

6. Function and health status outcomes in a randomized trial comparing preoperative and postoperative radiotherapy in extremity soft tissue sarcoma.

Authors: A M Davis; B O'Sullivan; R S Bell; R Turcotte; C N Catton; J S Wunder; P Chabot; A Hammond; V Benk; M Isler; C Freeman; K Goddard; A Bezjak; R A Kandel; A Sadura; A Day; K James; D Tu; J Pater; B Zee
Journal: J Clin Oncol Date: 2002-11-15 Impact factor: 44.544

7. Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.

Authors: Scott M Schuetze; Brian P Rubin; Cheryl Vernon; Douglas S Hawkins; James D Bruckner; Ernest U Conrad; Janet F Eary
Journal: Cancer Date: 2005-01-15 Impact factor: 6.860

8. Histologic response of dose-intense chemotherapy with preoperative hypofractionated radiotherapy for patients with high-risk soft tissue sarcomas.

Authors: Christopher W Ryan; Anthony G Montag; Janet R Hosenpud; Brian Samuels; James B Hayden; Arthur Y Hung; Atiya Mansoor; Terrance D Peabody; Arno J Mundt; Samir Undevia
Journal: Cancer Date: 2008-06 Impact factor: 6.860

9. Definitive radiotherapy and single-agent radiosensitizing ifosfamide in patients with localized, irresectable soft tissue sarcoma: a retrospective analysis.

Authors: Franziska Eckert; Christiane Matuschek; Arndt-Christian Mueller; Martin Weinmann; Joerg T Hartmann; Claus Belka; Wilfried Budach
Journal: Radiat Oncol Date: 2010-06-16 Impact factor: 3.481

10. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas.

Authors: Thomas F DeLaney; Ira J Spiro; Herman D Suit; Mark C Gebhardt; Francis J Hornicek; Henry J Mankin; Andrew L Rosenberg; Daniel I Rosenthal; Fariba Miryousefi; Marcus Ancukiewicz; David C Harmon
Journal: Int J Radiat Oncol Biol Phys Date: 2003-07-15 Impact factor: 7.038

3 in total